|
|
|
|
|
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)
|
|
|
|
Summary
|
|
|
Fund Name
|
ICICI Prudential Mutual Fund
|
|
Scheme Name
|
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)
|
|
AMC
|
ICICI Prudential Asset Management Company Limited
|
|
Type
|
Open ended scheme
|
|
Category
|
Equity - Sectoral Fund - Pharma & Health Care
|
|
Launch Date |
13-Jul-18
|
|
Fund Manager
|
Dharmesh Kakkad
|
|
Face Value
|
10
|
|
Custodian |
HDFC Bank Limited , Citibank N.A
|
|
Net Assets (Rs. cr)
|
5320.29
|
|
|
|
|
AMC Details |
|
ICICI Prudential Asset Management Company Limited
|
|
One BKC, A - Wing 13th Floor,
|
|
Bandra Kurla Complex, Bandra (East)
|
|
Mumbai - 400 051
|
|
Phone :
+91 (22) 2652 5000
|
|
Fax :
+91 (22) 2652 8100
|
|
enquiry@icicipruamc.com
|
|
www.icicipruamc.com
|
|
|
Registrar & Transfer Agent Details |
|
Computer Age Management Services Limited
|
|
178 / 10, Kodambakkam High Road,
|
|
Opp. Palmgroove Hotel, M.G.R. Salai, Nungambakkam,
|
|
Chennai - 600 034
|
|
(044) 39115574, 39115583
|
|
(044) 28291521
|
|
camslb@camsonline.com
|
|
www.camsonline.com
|
|
|
|
|
|
|
|
|
|
NAV Details
|
| |
|
|
NAV Date
|
30-Jan-25 |
Max Entry Load %
|
0.00 |
|
NAV [Rs] |
36.96 |
Max Exit Load %
|
1.00 |
|
Buy/Resale Price [Rs]
|
36.96 |
52 Week High[Rs] |
40.39 (02-Jan-25) |
|
Sell/Repurchase Price [Rs]
|
36.96 |
52 Week Low[Rs]
|
28.76 (01-Feb-24) |
|
|
|
|
|
Nav Graph |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment Details
|
|
Objective |
| To generate long-term capital appreciation by creating a portfolio that is invested in Equity and Equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.However there can be no assurance that the investment objectives of the scheme will be realized. |
|
|
|
Min. Investment(Rs.)
|
5000 |
|
Increm.Investment(Rs.)
|
1000 |
|
|
|
Investment Pattern |
| Type | Minimum % | Maximum % | | Equity & Equity related instruments of pharma, healthcare, diagnostics, wellness & allied comp | 80 | 100 | | Equity & Equity related instruments ofother than pharma, healthcare, diagnostics, wellness and allied comp | 0 | 20 | | Debt, Units of MF Schemes, MMI, Cash & Cash Equivalents | 0 | 20 |
|
|
|
|
SIP Details |
|
|
SIP MIN Investments(Rs.) |
100 |
|
SIP Incremental Investments(Rs.) |
1 |
|
SIP Frequency |
Daily |
|
No.of Investments Cheques
|
|
|
|
|
|
|
|
Ratio
|
| |
|
Statistical Ratios |
|
|
|
|
Standard Deviation [%] |
16.3080
|
|
Semi Standard Deviation [%] |
0.5690
|
|
Beta [%] |
0.5098
|
|
Sharpe Ratio [%] |
0.5124
|
|
R-Square [%] |
0.5250
|
|
Expense Ratio [%] |
1.9100
|
|
AVG Ratio [%] |
0.0300
|
|
|
|
|
Other Ratios |
|
|
|
|
Jenson Ratio [%] |
0.0767
|
|
Treynor Ratio [%] |
0.1639
|
|
Turnover Ratio [%] |
0.9500
|
|
FAMA Ratio [%] |
0.0758
|
|
SORTINO Ratio [%] |
0.0238
|
|
|
|
|
What is Standard Deviation?
Standard Deviation is the measure of the deviation in the returns of the portfolio. In Simple Words it tells us how much the return on the fund is deviating from the expected normal return.
|
|
|
What is Jenson's Alpha?
It measures whether the Scheme is generating excess returns over the normal returns.For example, if there are two mutual funds that both have a 12% return, a rational investor will want the fund that is less risky.If the value is positive, then the portfolio is earning excess returns. In other words, a positive value for Jensen's alpha means a fund manager has 'beat the market' w with his or her stock picking skills. The Higher the value the better the performance.
|
|
|
|
|
|
|
Portfolio Analysis
|
|
|
|
Allocations As on
31-Dec-2024
|
|
|
|
Fund Size :
5320.29
(Cr.) |
|
|
|
 |
|
 |
|
|
|
Market cap-wise Allocation Style |
|
|
|
Average Mkt Cap (Rs Cr) |
46934.04
|
|
Market Capitalization |
% of Portfolio
|
|
Large |
89.82
|
|
Mid |
8.26
|
|
Small |
NA
|
|
Note: Large-Cap = 5000 Crs. and above, Mid-Cap = 2000 Crs. to 5000 Crs. and
Small-Cap = less than 2000 Crs. |
|
|
|
|
|
|
Portfolio Concentration |
|
|
% Net Assets
|
|
Top 3 Sectors |
NA |
|
|
|
+ - Top 5 Holdings |
42.65 |
| Sun Pharma Inds. | 13.83 | | Cipla | 9.28 | | Dr. Reddy's Lab | 8.93 | | Divi's Lab | 5.56 | | Aurobindo Pharma | 5.05 |
|
|
+ - Top 10 Holdings |
61.21 |
| Sun Pharma Inds. | 13.83 | | Cipla | 9.28 | | Dr. Reddy's Lab | 8.93 | | Divi's Lab | 5.56 | | Aurobindo Pharma | 5.05 | | Lupin | 4.67 | | Alkem Laboratories | 3.98 | | Gland Pharma | 3.73 | | Mankind Pharma | 3.22 | | Zydus Lifesciences | 2.96 |
|
|
|
|
|
Sun Pharmaceutical Industries Ltd.
|
13.83
|
|
Cipla Ltd.
|
9.28
|
|
Dr. Reddy's Laboratories Ltd.
|
8.93
|
|
Divi's Laboratories Ltd.
|
5.56
|
|
Aurobindo Pharma Ltd.
|
5.05
|
|
Lupin Ltd.
|
4.67
|
Alkem Laboratories Ltd.
|
3.98
|
|
Gland Pharma Ltd.
|
3.73
|
|
Mankind Pharma Ltd.
|
3.22
|
|
Zydus Lifesciences Ltd.
|
2.96
|
|
|
  Indicates an increase or decrease or no change in holding since last portfolio |
 Indicates a new holding since last portfolio. |
 |
|
|
|
|
Sector Allocation * (as % of equity portfolio) |
|
|
|
Sector Allocation
Chart Type : |
 |
|
*Pertains to the equity investments only. |
|
|
|
|
|
|
|
|
|
|
In / Out
|
| |
| What's in as on 31-Dec-2024 |
|
What's out as on 31-Dec-2024 |
| Company Name | Mkt Value | Holdings | | (Rs.Cr) | % | | Senores Pharmaceuticals Ltd. | 72.709 | 1.3666 |
|
|
| Company Name | Mkt Value | Holdings | | (Rs.Cr) | % | | Krishna Institute of Medical Sciences Ltd | 50.4085 | 0.9992 | | Vijaya Diagnostic Centre Ltd. | 47.2766 | 0.9372 | | Sagility India Ltd. | 59.2051 | 1.1736 | | Wockhardt Ltd. | 50.8515 | 1.008 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
